Possible association of HLA-DRB1 gene with the autoantibody against myocardial mitochondria ADP/ATP carrier in dilated cardiomyopathy

Abstract

To probe the genetic background and immunopathogenesis of dilated cardiomyopathy (DCM) 77 patients with DCM, HLA-DRB1 gene polymorphism were analyzed by using the polymerase chain reaction/sequence specific primer (PCR/SSP) technique and autoantibody against myocardial mitochondria ADP/ATP carrier were examined by using the Immunoblot analysis. The frequency of HLA-DRB1*0901 allele was significantly higher in DCM patients in which autoantibody against ADP/ATP carrier of myocardial mitochondria is positive in contrast with those in which the autoantibody is negative (25.46% vs 3.45%,P<0.05), the relative risk (RR) being 9.56. The other frequencies of HLA-DRB1 alleles have no significant difference in the antibody positive group and negative group. It is possible that a subset of DCM patients may exist in which autoimmunity is associated with genetic factors.

Keywords

dilated cardiomyopathy / HLA / ADP/ATP carrier

References

[1] SchmidtM A, MickelsV V, EdwardsW D, et al.. Familial dilated cardiomyopathy. Am J Med Genet, 1988, 31: 135-135

[2] MichelsVV, MollPP, MillerFA, et al.. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med, 1992, 326: 77-77

[3] LimasC, LimasCJ, BoudoulasH, et al.. HLA-DQA1 and—DQB1 gene haplotypes in familial cardiomyopathy. Am J Cardiol, 1994, 74: 510-510

[4] OsaA, AlmenarL, PalenciaM, et al.. Antigens of the major histocompatibility system in ischemic heart disease and idiopathic dilated cardiomyopathy. Clin Cardiol, 1999, 22: 292-292

[5] LimasC J, LimasC, KuboS H, et al.. Anti-Beta-Receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens. Am J Cardiol, 1990, 65: 483-483

[6] CarlquistJ F, MonloveR L, MurrayM B, et al.. HLA Class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Circulation, 1991, 83: 515-515

[7] ArbustiniE, GavazziA, PozziR, et al.. The morphologic spectrum of dilated cardiomyopathy and it's relation to immune response genes. Am J Cardiolo, 1989, 64: 991-991

[8] LimasC J, LimasC, GoldenbergI F, et al.. Possible involvement of the HLA-DQB1 gene in susceptibility and resistance to human dilated cardiomyopathy. Am Heart J, 1995, 129: 1141-1141

[9] LiaoY-H. Functional analysis of autoantibodies against ADP/ATP carrier from dilated cardiomyopathy. International Journal of cardiology, 2002, 54: 165-165

[10] BodmerL G, MarshS G E, AlbertE D, et al.. Nomenclature for factors of the HLA system. Tissue Antigens, 1994, 44: 1-1

[11] BrandenburgR O, ChazovE, CherianG, et al.. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J, 1980, 44: 672-672

[12] OlerupO, ZetterquistH. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantations. Tissue Antigens, 1992, 39: 225-225

[13] LiaoY H, TuY S, LiS L, et al.. A study of the autoantibody against an ADP/ATP carrier of myocardial mitochondria in dilated cardiomyopathy. Chinese J Cardiol, 1994, 22: 43-43

[14] CaforioA L, GoldmanJ H, HavenA J, et al.. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int J cardiol, 2002, 54: 157-157